Idiopathic granulomatous mastitis: Overcoming this important clinical challenge

2Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

The aim of this study was to determine possible risk factors for recurrence development in patients with idiopathic granulomatous mastitis (IGM). Demographic, clinical, radiologic, and histopathologic characteristics of 34 consecutive patients with IGM were retrospectively reviewed. Also, 32 patients who were informed about recurrence status were divided into non-recurrent (n = 27) and recurrent (n = 5) groups. Both groups were compared for demographic and clinical parameters. This study included 34 female patients with IGM aged between 26 and 70 years (median: 38 years). During the followup period, no recurrence occurred in 27 patients whereas recurrence developed in 5 patients. No significant difference was found between the groups with respect to age, lesion size, breast-feeding, number of child, marital status, use of oral contraceptive, familial or personal tuberculosis history, PPD test, smoking, lesion side, lesion location on the breast, and treatment choice. The diagnostic tools of the IGM as follows: tru-cut (n = 18); incisional (n = 6); tru-cut + incisional (n = 5); tru-cut + excisional (n = 2); tru-cut + FNAB (n = 1); FNAB + excisional (n = 1) and FNAB (n = 1). Treatment options were as follow: antibiotics + drainage (n = 10); antibiotics + drainage + corticosteroid (n = 9); wait and watch (n = 6); corticosteroid (n = 3); antibiotics + antituberculous (n = 1); antituberculous (n = 1); antibiotics + breast conserving surgery + chemotherapy (n = 1); modified radical mastectomy + chemotherapy + radiotherapy (n = 1); and no available (n = 2). This study shows that no demographic and clinical data contributes to the development of recurrence disease. To give a strong message, this study should be supported by other high volume and prospective studies.

References Powered by Scopus

The role of conservative treatment in idiopathic granulomatous mastitis

206Citations
N/AReaders
Get full text

Idiopathic Granulomatous Mastitis: A 25-Year Experience

182Citations
N/AReaders
Get full text

Prednisone Management of Granulomatous Mastitis

177Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Risk Factors and the Role of the Albumin-to-Globulin Ratio in Predicting Recurrence Among Patients with Idiopathic Granulomatous Mastitis

11Citations
N/AReaders
Get full text

Treatment modalities for granulomatous mastitis, seeking the most appropriate treatment with the least recurrence rate: a systematic review and meta-analysis

6Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Emre, A., Akbulut, S., Sertkaya, M., Bitiren, M., Kale, I. T., Bulbuloglu, E., & Yurttutan, N. (2019). Idiopathic granulomatous mastitis: Overcoming this important clinical challenge. International Surgery, 103(5–6), 228–237. https://doi.org/10.9738/INTSURG-D-16-00225.1

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

67%

Researcher 2

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

89%

Business, Management and Accounting 1

11%

Save time finding and organizing research with Mendeley

Sign up for free